Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|June 18, 2013
Preclinical HER-2 Vaccines: From Rodent to Human HER-2Pier-Luigi Lollini, Carla De Giovanni, Patrizia NanniExpert Review of Vaccines|November 8, 2013
Preclinical vaccines against mammary carcinomaPier-Luigi Lollini, Federica Cavallo, Carla De Giovanni, et al.Cancer Immunology, Immunotherapy : CII|January 27, 2011
2011: the immune hallmarks of cancerFederica Cavallo, Carla De Giovanni, Patrizia Nanni, et al.Future Oncology (London, England)|November 12, 2009
Molecular and cellular biology of rhabdomyosarcomaCarla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.The Breast Journal|November 6, 2010
Immunoprevention and immunotherapy of mammary carcinomaPier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.The Journal of Biological Chemistry|February 28, 2009
Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICESuniti Misra, Vincent C Hascall, Carla De Giovanni, et al.Current Pharmaceutical Biotechnology|July 12, 2011
The molecular basis of herpesviruses as oncolytic agentsLaura Menotti, Gabriella Campadelli-Fiume, Patrizia Nanni, et al.Cancers|December 1, 2019
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental ModelCarla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, et al.Cells|August 7, 2021
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted TherapyCarla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.Future Oncology (London, England)|March 25, 2006
Cancer immunopreventionPier-Luigi Lollini, Carla De Giovanni, Tania Pannellini, et al.Pageof 6